DJIA 16,574.72 -305.64 -1.81%
NASDAQ 4,368.60 -94.30 -2.11%
S&P 500 1,933.28 -36.79 -1.87%
market minute promo

2.07 -0.09 (-4.17%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CYTX $2.07 -4.17%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.10
Previous Close $2.16
Daily Range $2.03 - $2.12
52-Week Range $2.00 - $3.93
Market Cap $156.2M
P/E Ratio -5.14
Dividend (Yield) $0.00 (0.0%)
Volume 279,902
Average Daily Volume 344,005
Current FY EPS -$0.37

Sector

Healthcare

Industry

Drugs

Cytori Therapeutics, Inc. (USA) (CYTX) Description

A developing company which seeks to commercialize stem and regenerative cell therapies for cardiovascular disease, reconstructive surgery and many other serious, chronic, and life threatening conditions. Website: http://www.cytori.com/

News & Commentary Rss Feed

Fast and Furious Health Care Stocks This Week

MannKind, Cytori Therapeutics, and Omeros are among the health care stocks soaring this week.

2 Small Cap Biotechs Insiders And Analysts Are Positive On

Morning Market Movers

Sector Update: Healthcare Shares Flat Pre-Market; Cytori Down 1% on Plans to Sell 4 Mln Units

Cytori Therapeutics' (CYTX) CEO Marc Hedrick on Q1 2014 Results - Earnings Call Transcript

Cytori Therapeutics Announces Date For Crucial BARDA Meeting

Cytori Announces Senior Management Changes; Christopher Calhoun CEO and Director of Cytori Therapeut

Cytori Announces Senior Management Changes; Christopher Calhoun CEO and Director of Cytori Therapeutics, is Retiring as CEO of the Company, Effective Immediately

4 Stocks Under $10 Triggering Breakouts

Cytori Therapeutics: Global Patient Stem Cell Demand Builds, Important Short-Term Catalysts Ahead

Cytori Therapeutics Is A Cell Therapy Company With Several Positive Catalysts For 2014

A Glimpse At Our Small Cap Biotechnology Portfolio

See More CYTX News...

CYTX's Top Competitors

CYTX $2.07 (-4.17%)
Current stock: CYTX
AMGN $127.73 (-1.75%)
Current stock: AMGN
GILD $91.68 (-2.25%)
Current stock: GILD
BIIB $335.55 (-2.60%)
Current stock: BIIB